Gottlieb, who led the agency during the first Trump presidency, supports a reversion to an earlier interpretation of the 21st Century Cures Act.

Before taking his role at the FDA Gottlieb published a long list of pharma and biotech companies that he had worked with, and had to recuse himself from his role as a board member for medical ...

Opens in a new tab or window In its final days, the Biden administration's FDA is expected to propose a limit on the amount of nicotine in cigarettes. (NBC News) And House members Frank Pallone Jr ...

H1 is strengthening its leadership team with the appointment of former FDA Commissioner Dr. Stephen M. Hahn to its board; announcing the strategic acquisition of Ribbon Health; and unveiling a ...

During the transition period, Lykos will work with a number of shareholders to secure financing for an additional Phase III trial of midomafetamine capsules for post-traumatic stress disorder. Lykos ...